Globus Medical, Inc. (GMED) Insider Trading Activity

NYSE$89.29+0.01 (0.01%)
Market Cap
$12.08B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
590 of 883
Rank in Industry
75 of 113

GMED Insider Trading Activity

GMED Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$11,691,296
12
100

Related Transactions

Norwalk Leslie Vdirector
0
$0
2
$557,600
$-557,600
RHOADS ANN Ddirector
0
$0
3
$1.4M
$-1.4M
Kline KyleSenior Vice President, CFO
0
$0
2
$2.03M
$-2.03M
ZARRILLI STEPHEN Tdirector
0
$0
1
$2.11M
$-2.11M
Davidar David Ddirector
0
$0
1
$2.15M
$-2.15M
Huller KellySVP, GC, Corporate Secretary
0
$0
3
$3.44M
$-3.44M

About Globus Medical, Inc.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Insider Activity of Globus Medical, Inc.

Over the last 12 months, insiders at Globus Medical, Inc. have bought $0 and sold $11.69M worth of Globus Medical, Inc. stock.

On average, over the past 5 years, insiders at Globus Medical, Inc. have bought $0 and sold $17.86M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 615 shares for transaction amount of $33,136 was made by Douglas Robert Andrew (director) on 2020‑08‑24.

List of Insider Buy and Sell Transactions, Globus Medical, Inc.

2026-02-25SaleHuller KellyEVP, GC, Corporate Secretary
20,000
0.0147%
$94.50
$1.89M
-3.27%
2026-02-12SaleHuller KellyEVP, GC, Corporate Secretary
10,000
0.0075%
$87.67
$876,700
+3.34%
2026-01-08SaleNorwalk Leslie Vdirector
2,000
0.0016%
$101.10
$202,200
-4.02%
2026-01-08SaleKline KyleSenior Vice President, CFO
3,594
0.0029%
$101.10
$363,353
-4.02%
2025-12-12SaleNorwalk Leslie Vdirector
4,000
0.0031%
$88.85
$355,400
+3.99%
2025-12-01SaleKline KyleSenior Vice President, CFO
18,542
0.0139%
$90.00
$1.67M
+0.11%
2025-11-25SaleHuller KellySVP, GC, Corporate Secretary
7,500
0.0059%
$90.00
$675,000
-1.40%
2025-11-12SaleDavidar David Ddirector
25,000
0.019%
$86.00
$2.15M
+5.51%
2025-11-11SaleZARRILLI STEPHEN Tdirector
25,000
0.0187%
$84.29
$2.11M
+5.20%
2025-11-10SaleRHOADS ANN Ddirector
2,000
0.0015%
$85.00
$170,000
+3.40%
2025-11-07SaleRHOADS ANN Ddirector
8,000
0.0079%
$81.00
$648,000
+6.37%
2025-09-15SaleRHOADS ANN Ddirector
10,000
0.0074%
$58.46
$584,600
+50.52%
2025-02-28SaleRHOADS ANN Ddirector
7,500
0.0046%
$78.68
$590,100
-21.53%
2025-01-10SalePfeil Keith WCOO, CFO
14,167
0.0105%
$88.29
$1.25M
-27.61%
2024-12-02SaleHuller KellySVP, GC, Corporate Secretary
2,500
0.0019%
$87.00
$217,502
-24.87%
2024-11-22SaleDavidar David Ddirector
13,512
0.01%
$85.00
$1.15M
-25.87%
2024-11-22SaleLemaitre Dandirector
1,097
0.0008%
$85.02
$93,263
-25.87%
2024-11-21SaleDavidar David Ddirector
26,488
0.0195%
$85.00
$2.25M
-25.77%
2024-11-21SaleScavilla Daniel TPresident, CEO
130,000
0.0957%
$85.00
$11.05M
-25.77%
2024-11-21SaleLemaitre Dandirector
13,278
0.0098%
$85.00
$1.13M
-25.77%
Total: 146
*Gray background shows transactions not older than one year

Insider Historical Profitability

25.46%
Davidar David Ddirector
516275
0.3817%
$46.09M024
RHOADS ANN Ddirector
15384
0.0114%
$1.37M05
Norwalk Leslie Vdirector
10419
0.0077%
$930,208.3204
ZARRILLI STEPHEN Tdirector
0
0%
$001
Huller KellyEVP, GC, Corporate Secretary
0
0%
$0017
Kline KyleSenior Vice President, CFO
0
0%
$002
Clarus Lifesciences I, L.P.10 percent owner
7244201
5.356%
$646.76M01
WHEELER KURTdirector
44319
0.0328%
$3.96M03
Murphy A BrettGroup President, Commerical Op
35217
0.026%
$3.14M08
LIPTAK ROBERTdirector
26159
0.0193%
$2.34M04
Douglas Robert Andrewdirector
2005
0.0015%
$179,006.4030
+25.46%
TOBIN JAMES R
0
0%
$007
BARON RICHARD ASenior VP and CFO
0
0%
$001
Schwartz EricSenior VP and General Counsel
0
0%
$002
Lemaitre Dandirector
0
0%
$005
Paul David CExecutive Chairman
0
0%
$009
Demski David MPresident, CEO
0
0%
$0025
Payne StevenChief Accounting Officer
0
0%
$005
Williams Anthony LPresident
0
0%
$006
Scavilla Daniel TPresident, CEO
0
0%
$006
Pfeil Keith WCOO, CFO
0
0%
$008
*Gray background shows insiders who have made transactions during last year

GMED Institutional Investors: Active Positions

Increased Positions280+44.59%19M+16.29%
Decreased Positions283-45.06%19M-16.01%
New Positions123New5MNew
Sold Out Positions55Sold Out5MSold Out
Total Postitions625-0.48%117M+0.28%

GMED Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$925,882.009.47%10.61M-103,146-0.96%2025-09-30
Blackrock, Inc.$919,559.009.4%10.53M-230,169-2.14%2025-09-30
Janus Henderson Group Plc$659,345.006.74%7.55M-654,262-7.97%2025-09-30
Jpmorgan Chase & Co$321,435.003.29%3.68M+341,201+10.21%2025-09-30
Sculptor Capital Lp$305,550.003.13%3.5M+739,312+26.78%2025-09-30
State Street Corp$302,199.003.09%3.46M-11,766-0.34%2025-09-30
Burgundy Asset Management Ltd.$302,144.003.09%3.46M-20,455-0.59%2025-09-30
William Blair Investment Management, Llc$246,113.002.52%2.82M+414,134+17.22%2025-09-30
Madison Avenue Partners, Lp$222,455.002.28%2.55M+836,015+48.83%2025-09-30
Geneva Capital Management Llc$181,928.001.86%2.08M+1,151+0.06%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.